Robocath announced that it launched a first-in-human clinical study evaluating its new robotic system in coronary artery disease.
The Rouen, France-based company said its second-generation...
ReGelTec Inc., a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced the...
Epiminder announced the first implantation of its Minder System in the US, a device developed for ongoing monitoring of epilepsy.
The procedure took place at...
Heart Failure Solutions, a clinical-stage medtech company based outside Minneapolis, announced the first successful in-human use of its PeriCut system, designed to treat patients...
JenaValve announced new results from an expanded patient cohort supporting the use of its Trilogy transcatheter heart valve (THV) system.
Results from the ALIGN-AR pivotal...
Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...
Hyperion Surgical announced today that it completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy platform.
Ivy integrates advanced imaging, AI and robotic...
AtriCure, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...
Penumbra announced positive results from its landmark STORM-PE randomised controlled trial.
The study found that the use of the company’s computer-assisted vacuum thrombectomy (CAVT) system,...